{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:57:16Z","timestamp":1760237836010,"version":"build-2065373602"},"reference-count":97,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ecl.2015.02.010","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T07:00:19Z","timestamp":1432969219000},"page":"355-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Primary Aldosteronism"],"prefix":"10.1016","volume":"44","author":[{"given":"Sandi-Jo","family":"Galati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ecl.2015.02.010_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"669","author":"Young","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2015.02.010_bib2","first-page":"3","article-title":"Presidential address. Part I: painting background. Part II: primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.ecl.2015.02.010_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical characteristics of primary aldosteronism from analysis of 145 cases","volume":"107","author":"Conn","year":"1964","journal-title":"Am J Surg"},{"key":"10.1016\/j.ecl.2015.02.010_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.1964.03070160046009","article-title":"Plasma renin activity in primary aldosteronism: importance in differential diagnosis and in research of essential hypertension","volume":"190","author":"Conn","year":"1964","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2015.02.010_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.1968.03140330039007","article-title":"Incidence of primary aldosteronism uncomplicated \u201cessential\u201d hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria","volume":"205","author":"Fishman","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2015.02.010_bib6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","article-title":"Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism","volume":"66","author":"Kaplan","year":"1967","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ecl.2015.02.010_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High prevalence in primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2015.02.010_bib8","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2015.02.010_bib9","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ecl.2015.02.010_bib10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ecl.2015.02.010_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.ecl.2015.02.010_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary aldosteronism in moderate to severe hypertension in the Central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"J\u00a0Hum Hypertens"},{"issue":"1","key":"10.1016\/j.ecl.2015.02.010_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1479164109350556","article-title":"Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism","volume":"7","author":"Mukherjee","year":"2010","journal-title":"Diab Vasc Dis Res"},{"issue":"7","key":"10.1016\/j.ecl.2015.02.010_bib14","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/dc07-0031","article-title":"Primary aldosteronism in diabetic subjects with resistant hypertension","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ecl.2015.02.010_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/10641963.2012.712175","article-title":"Prevalence of primary aldosteronism in hypertensive subjects with hyperglycemia","volume":"35","author":"Li","year":"2013","journal-title":"Clin Exp Hypertens"},{"issue":"3","key":"10.1016\/j.ecl.2015.02.010_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"issue":"6","key":"10.1016\/j.ecl.2015.02.010_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF02596419","article-title":"Screening for primary aldosteronism: hypokalemia in hypertensive patients","volume":"1","author":"Goldenberg","year":"1986","journal-title":"J\u00a0Gen Intern Med"},{"issue":"3","key":"10.1016\/j.ecl.2015.02.010_bib18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11154-011-9160-x","article-title":"Primary aldosteronism: A contrarian view","volume":"12","author":"Kaplan","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.ecl.2015.02.010_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pcad.2009.12.003","article-title":"Aldosterone and mineralocorticoid receptors in the cardiovascular system","volume":"53","author":"Funder","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ecl.2015.02.010_bib21","series-title":"Williams textbook of endocrinology","first-page":"545","article-title":"Endocrine hypertension","author":"Young","year":"2012"},{"key":"10.1016\/j.ecl.2015.02.010_bib22","doi-asserted-by":"crossref","first-page":"E674","DOI":"10.1210\/jc.2013-2900","article-title":"Lower expression of TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism","volume":"99","author":"Lenzini","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01102","article-title":"MicroRNA-24 is a novel regulator of aldosterone and cortisol production in the human adrenal cortex","volume":"62","author":"Robertson","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/\u03b2-catenin signaling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ecl.2015.02.010_bib25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/HYPERTENSIONAHA.112.202945","article-title":"Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of an aldosterone-producing adenoma","volume":"61","author":"Rossiotto","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A\u00a0chimaeric 11b\u2013hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism in human hypertension","volume":"355","author":"Lifton","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ecl.2015.02.010_bib27","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A\u00a0novel form of mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib28","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ecl.2015.02.010_bib29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"52","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/HYPERTENSIONAHA.111.186239","article-title":"Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas","volume":"59","author":"Azizan","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib31","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib32","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculate-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib33","doi-asserted-by":"crossref","first-page":"E1567","DOI":"10.1210\/jc.2011-3132","article-title":"Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells","volume":"97","author":"Monticone","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib34","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2015.02.010_bib35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/HYPERTENSIONAHA.113.02234","article-title":"Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism","volume":"63","author":"Murthy","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11906-012-0297-0","article-title":"The ubiquitous mineralocorticoid receptor: clinical implications","volume":"14","author":"Hawkins","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ecl.2015.02.010_bib37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.110.161653","article-title":"GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone","volume":"57","author":"Gros","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib38","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/HJH.0b013e32833d0177","article-title":"Increased oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients","volume":"28","author":"Stehr","year":"2010","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib39","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1210\/jc.2011-1135","article-title":"Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis","volume":"96","author":"Wu","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib40","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1210\/jc.2006-0101","article-title":"Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism","volume":"91","author":"Rizzoni","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib41","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","article-title":"Increased intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"25","author":"Holaj","year":"2007","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib42","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib43","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn\u2019s adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2015.02.010_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjhyper.2005.05.013","article-title":"Role of aldosterone in left ventricular hypertrophy in hypertension","volume":"19","author":"Matsumura","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib45","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2015.02.010_bib46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/HYPERTENSIONAHA.108.114140","article-title":"Inappropriate left ventricular mass in patients with primary aldosteronism","volume":"52","author":"Muiesan","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib47","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jc.2008-2116","article-title":"Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn\u2019s registry","volume":"94","author":"Born-Frontsberg","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib48","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib50","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0031-1295412","article-title":"Aldosterone and metabolic syndrome","volume":"44","author":"Fallo","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2015.02.010_bib51","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jc.2012-3934","article-title":"Aldosterone excess impairs first phase insulin secretion in primary aldosteronism","volume":"98","author":"Fischer","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib52","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1210\/jc.2008-0251","article-title":"Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients","volume":"93","author":"Rossi","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0029-1246189","article-title":"Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn\u2019s registry","volume":"42","author":"Reincke","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2015.02.010_bib54","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/HJH.0b013e3283492219","article-title":"Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population","volume":"29","author":"Sim","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib55","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib56","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0b013e328126855b","article-title":"Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment","volume":"25","author":"Novello","year":"2007","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib57","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Participants of German Conn's Registry. Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2015.02.010_bib58","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0031-1295461","article-title":"Aldosterone and the kidney","volume":"44","author":"Fourkiotis","year":"2012","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.ecl.2015.02.010_bib59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/15622975.2012.665480","article-title":"Gender differences in anxiety and depressive symptoms in patients with primary aldosteronism: a cross-sectional study","volume":"15","author":"Apostolopoulou","year":"2012","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.ecl.2015.02.010_bib60","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","author":"Salcuni","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2015.02.010_bib61","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00004872-200103000-00002","article-title":"Primary aldosteronism: revival of a syndrome","volume":"19","author":"Stowasser","year":"2000","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib63","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00268-001-0033-4","article-title":"Primary aldosteronism: are we diagnosing and operating on too few patients?","volume":"25","author":"Gordon","year":"2001","journal-title":"World J Surg"},{"key":"10.1016\/j.ecl.2015.02.010_bib64","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u2018non-selective\u2019 screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004872-200402000-00006","article-title":"The challenge of a more robust and reproducible methodology in screening for primary aldosteronism","volume":"22","author":"Gordon","year":"2004","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib66","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2015.02.010_bib67","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/sj.jhh.1002024","article-title":"Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension","volume":"20","author":"Doi","year":"2006","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib68","first-page":"597","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"4","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib69","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-11-0287","article-title":"Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates","volume":"165","author":"Betz","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2015.02.010_bib70","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/ajh.2011.148","article-title":"Intraprocedural cortisol measurement increased adrenal vein sampling success rate in primary aldosteronism","volume":"24","author":"Rossi","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib71","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism","volume":"2","author":"Stowasser","year":"2001","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ecl.2015.02.010_bib72","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-13-0741","article-title":"Evaluation of right adrenal vein cannulation by computed tomography angiography in 140 consecutive patients undergoing adrenal venous sampling","volume":"170","author":"Onozawa","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2015.02.010_bib73","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2015.02.010_bib74","first-page":"564","article-title":"Primary aldosteronism associated with subclinical Cushing syndrome","volume":"36","author":"Fujimoto","year":"2013","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.ecl.2015.02.010_bib75","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/HYPERTENSIONAHA.113.01601","article-title":"Plasma metanephrine for assessing the selectivity of adrenal venous sampling","volume":"62","author":"Dekkers","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib76","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12020-012-9793-x","article-title":"Are catecholamine-derived indexes in adrenal venous sampling useful for judging selectivity and laterality in patients with primary aldosteronism?","volume":"43","author":"Baba","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.ecl.2015.02.010_bib77","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2013-4146","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism","volume":"99","author":"Lim","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib78","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","article-title":"Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome","volume":"141","author":"Nwariaku","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.ecl.2015.02.010_bib79","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/jc.2012-1917","article-title":"A\u00a0clinical prediction score to diagnose unilateral primary aldosteronism","volume":"97","author":"K\u00fcpers","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2015.02.010_bib80","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1210\/jc.2013-3789","article-title":"Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal vein sampling in primary aldosteronism","volume":"90","author":"Reister","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib81","first-page":"25","article-title":"Diagnosing unilateral primary aldosteronism - comparison of a clinical prediction score, computed tomography and adrenal venous sampling","volume":"81","author":"Candy","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2015.02.010_bib82","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1365-2168.2002.02261.x","article-title":"Long-term follow-up and cost benefit of adrenalectomy in patients with primary aldosteronism","volume":"89","author":"Sywak","year":"2002","journal-title":"Br J Surg"},{"key":"10.1016\/j.ecl.2015.02.010_bib83","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/HJH.0b013e3283060f0c","article-title":"Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma","volume":"26","author":"Letavernier","year":"2008","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib84","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00268-004-7496-z","article-title":"Long-term follow-up after adrenalectomy for primary aldosteronism","volume":"29","author":"Meyer","year":"2005","journal-title":"World J Surg"},{"key":"10.1016\/j.ecl.2015.02.010_bib85","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0029-1246185","article-title":"Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism","volume":"42","author":"Catena","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2015.02.010_bib86","doi-asserted-by":"crossref","first-page":"104","DOI":"10.9738\/CC140.1","article-title":"Predictors of successful outcome after adrenalectomy for primary aldosteronism","volume":"97","author":"Wang","year":"2012","journal-title":"Int Surg"},{"key":"10.1016\/j.ecl.2015.02.010_bib87","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","article-title":"Medical management of aldosterone-producing adenomas","volume":"131","author":"Ghose","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2015.02.010_bib88","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxy-spirolactone derivatives: characterization in\u00a0vivo and in\u00a0vitro","volume":"240","author":"De Gasparo","year":"1987","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ecl.2015.02.010_bib89","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A\u00a0double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib90","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","article-title":"A\u00a0review of the medical treatment of primary aldosteronism","volume":"19","author":"Lim","year":"2001","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib91","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/HJH.0b013e32835d6d49","article-title":"Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism","volume":"31","author":"Amar","year":"2013","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2015.02.010_bib92","first-page":"274","article-title":"Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment","volume":"35","author":"Bernini","year":"2012","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.ecl.2015.02.010_bib93","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn's registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2015.02.010_bib94","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/s-0029-1246186","article-title":"Confirmatory tests in the diagnosis of primary aldosteronism","volume":"42","author":"Mulatero","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2015.02.010_bib95","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","article-title":"Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study","volume":"99","author":"Ahmed","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.02.010_bib96","first-page":"156","article-title":"Captopril suppression: limitations for confirmation of primary aldosteronism","volume":"2","author":"Westerdahl","year":"2001","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ecl.2015.02.010_bib97","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2362.2011.02531.x","article-title":"High prevalence of autonomous aldosterone secretion among patients with essential hypertension","volume":"41","author":"Gouli","year":"2011","journal-title":"Eur J Clin Invest"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852915000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852915000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:40:34Z","timestamp":1760175634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852915000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0889852915000110"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2015.02.010","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2015.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}